The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

One of the most significant immune changes during menopause is an increase in pro-inflammatory cytokines, such as TNF-α and ...

A lupus diagnosis can profoundly affect many aspects of a man’s life, from sense of identity and mental health to the way one ...

Lupus, an autoimmune disorder, presents skin manifestations like the butterfly rash, often mimicked by conditions such as ...

Medically reviewed by Stella Bard, MD Lupus is a chronic autoimmune disease in which your immune system mistakenly attacks ...

Autoimmune diseases, especially in women, are associated with nearly a twofold increased risk for affective disorders, new ...

OMRF’s Dr. Jacquelyn Gorman receives $1M DoD grant to study gene variant linked to lupus, aiming to improve early detection ...

Over 300 attendees raised $450,000 to fuel research breakthroughs for those living with lupus SUMMIT, N.J., June 24, 2025 ...

The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for children aged 5 years of older with active lupus nephritis (LN) who are receiving standard therapy.

Your eyes can sometimes reveal early signs of problems in the body, including your kidneys. Certain eye symptoms may be ...